Product Usage
This product is intended for research purposes only. All product information available on this website is for educational purposes only. This product is not intended for consumption or bodily introduction of any kind. It should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Triple Regulator TIA-39-C20
PURITY ≥99%/LOT LL-0824/HPLC VERIFIED
Select Your Dosage
Triple Regulator TIA-39-C20 — GLP-1/GIP/Glucagon Triple Receptor Agonist.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Not intended for consumption of any kind.
03 / Research Context
Research context
TIA-39-C20 is a triple incretin receptor agonist targeting GLP-1, GIP, and glucagon receptors. It provides comprehensive metabolic modulation, influencing insulin secretion, adipose regulation, and hepatic lipid oxidation.
Key research areas
- Triple-agonist: GLP-1 + GIP + Glucagon
- Maximum metabolic impact of any incretin compound
- GLP-1: appetite suppression + insulin secretion
- GIP: insulin sensitivity + adipose regulation
- Glucagon: thermogenesis + hepatic fat oxidation
- Highest efficacy in preclinical weight studies
Handling & reconstitution
Supplied as a lyophilized powder. Bacteriostatic water is the recommended solvent for reconstitution in research applications. Store unreconstituted product at -20°C; reconstituted solutions should be stored at 2-8°C and used within 14–30 days.
Research use only. Not for human consumption.
Product specifications
| Type | GLP-1/GIP/Glucagon Triple Receptor Agonist |
| Purity | 99%+ |
| Appearance | Lyophilized Powder |
| Storage | 2-8°C |
